for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Corindus Vascular Robotics Inc

CVRS.A

Latest Trade

4.25USD

Change

0.00(0.00%)

Volume

1,204,124

Today's Range

4.25

 - 

4.26

52 Week Range

0.78

 - 

4.30

As of on the NYSE MKT LLC ∙ Minimum 15 minute delay

Pricing

Previous Close
4.25
Open
4.25
Volume
1,204,124
3M AVG Volume
79.36
Today's High
4.26
Today's Low
4.25
52 Week High
4.30
52 Week Low
0.78
Shares Out (MIL)
208.14
Market Cap (MIL)
884.58
Forward P/E
-22.37
Dividend (Yield %)
--

Latest Developments

More

Corindus Vascular Robotics QTRLY Loss Per Share $0.06

Siemens Healthineers: We Don't Expect Philips To Intervene In Planned Acquisition Of Corindus

Corindus Vascular Robotics Inc Files Prospectus Related To Offering & Resale Of Up To 14.4 Million Shares Of Common Stock

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Corindus Vascular Robotics Inc

Corindus Vascular Robotics, Inc. is engaged in robotic-assisted vascular interventions. The Company's CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System it brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. It operates through the development, marketing and sales of robotic-assisted vascular interventions segment. The CorPath System enables the robotic-assisted control of coronary guidewires and balloon/stent devices from the safety of a radiation-protected, ergonomic interventional cockpit. The CorPath System consists of two components: a bedside unit and an interventional cockpit.

Industry

Medical Equipment & Supplies

Contact Info

309 Waverley Oaks Rd Ste 105

+1.508.6533335

http://www.corindus.com/

Key Stats

3.00 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.0K

2017

0.0K

2018

0.0K

2019(E)

0.0K
EPS (USD)

2016

-0.280

2017

-0.200

2018

-0.220

2019(E)

-0.190
Price To Earnings (TTM)
--
Price To Sales (TTM)
58.04
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
80.93
LT Debt To Equity (MRQ)
60.76
Return on Investment (TTM)
-107.84
Return on Equity (TTM)
-83.49

Latest News

BRIEF-Corindus Reports Qtrly Loss Per Share $0.08

* QTRLY LOSS PER SHARE $0.08 Source text for Eikon: Further company coverage:

BRIEF-Corindus Vascular Robotics Offering, Resale By Selling Stockholders Of Up To 40.8 Mln Shares Of Common Stock

* OFFERING, RESALE BY SELLING STOCKHOLDERS OF UP TO 40.8 MILLION SHARES OF COMMON STOCK OF CO Source text: (https://bit.ly/2vf0U4I) Further company coverage:

BRIEF-Corindus Vascular Robotics Files For Non-Timely 10-K

* CORINDUS VASCULAR ROBOTICS INC FILES FOR NON-TIMELY 10-K - SEC FILING Source text: (http://bit.ly/2Iyhn6q) Further company coverage:

BRIEF-Corindus Announces $25 Mln Private Placement Of Series A Convertible Preferred Shares And Warrants

* CORINDUS ANNOUNCES $25 MILLION PRIVATE PLACEMENT OF SERIES A CONVERTIBLE PREFERRED SHARES AND WARRANTS

BRIEF-Corindus Reports Qtrly Loss Per Share $0.04

* QTRLY LOSS PER SHARE $0.04 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Corindus Receives FDA Clearance For First Automated Robotic Movement In Techniq Series For Corpath Grx Platform

* CORINDUS RECEIVES FDA CLEARANCE FOR FIRST AUTOMATED ROBOTIC MOVEMENT IN TECHNIQ SERIES FOR CORPATH GRX PLATFORM Source text for Eikon: Further company coverage:

BRIEF-Corindus Receives FDA Clearance For Corpath® Grx System In Peripheral Vascular Interventions

* CORINDUS RECEIVES FDA CLEARANCE FOR CORPATH® GRX SYSTEM IN PERIPHERAL VASCULAR INTERVENTIONS Source text for Eikon: Further company coverage:

BRIEF-Corindus Sees Q4 2017 Revenue $4.0 Mln To $4.2 Mln

* CORINDUS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 REVENUE

BRIEF-Corindus Vascular posts Q3 revenue of $2.4 million

* Corindus vascular robotics reports third quarter 2017 results

BRIEF-Corindus Vascular Robotics Q2 ‍loss per share $0.04​

* Corindus Vascular Robotics reports second quarter 2017 results

BRIEF-Corindus Vascular Robotics says PRECISION Registry data on robotic-assisted PCI presented during late breaking clinical trial session at SCAI 2017

* PRECISION Registry Data on robotic-assisted PCI presented during late breaking clinical trial session at SCAI 2017

BRIEF-Corindus Vascular Robotics reports Q1 revenue $800,000

* Corindus Vascular Robotics reports first quarter 2017 results

BRIEF-Corindus Vascular Robotics announces strategic partnership with Bloxr Solutions

* Announces strategic partnership with Bloxr Solutions to distribute line of radiation protection products

BRIEF-Corindus Vascular Robotics files for mixed shelf of up to $60 mln

* Files for mixed shelf of up to $60 million - sec filing Source text - http://bit.ly/2puLTot Further company coverage:

BRIEF-Corindus Vascular Robotics offering and resale by selling stockholders of 68.1 mln shares

* Corindus Vascular Robotics Inc - offering and resale by selling stockholders of 68.1 million shares of common stock of co - sec filing Source text - http://bit.ly/2puLTot Further company coverage:

BRIEF-Koninklijke Philips reports 15.5 pct stake in Corindus Vascular Robotics

* Koninklijke Philips N.V. Reports 15.5 percent stake in Corindus Vascular Robotics Inc, as of February 28, 2017 - sec filing

BRIEF-Hudson Executive Capital reports 6.1 pct stake in Corindus Vascular Robotics

* Hudson Executive Capital LP reports 6.1 percent stake in Corindus Vascular Robotics Inc as on February 28, 2017 - SEC filing

BRIEF-Arthur Cohen reports stake of 28.1 pct in Corindus Vascular Robotics as on Feb 28 - SEC Filing

* Arthur Cohen reports stake of 28.1 percent in Corindus Vascular Robotics Inc as on February 28, 2017 - SEC Filing Source text: [http://bit.ly/2n5l6h2] Further company coverage:

BRIEF-Corindus Vascular Robotics announces private placement for $45 mln

* Corindus Vascular Robotics announces private placement for $45 million

BRIEF-CORINDUS VASCULAR ROBOTICS INC SAYS BEGAN LIMITED INSTALLATIONS OF CORPATH GRX SYSTEM IN JAN 2017

* CORINDUS VASCULAR ROBOTICS INC - BEGAN LIMITED INSTALLATIONS OF CORPATH GRX SYSTEM IN JAN 2017 WITH PLANS FOR FULL COMMERCIAL LAUNCH IN LATE FEBRUARY Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up